Who was studied, and against what?

Results in one patient group do not automatically describe another. Check the study population, the comparison treatment and the follow-up period. A placebo-controlled result is not evidence that one new medicine is better than every existing option.

Look for the number of participants and the outcome actually measured. A change in body weight, a symptom score and a cardiovascular event are different outcomes.

Which analysis produced the number?

An analysis estimating outcomes while participants remain on treatment can answer a different question from one including the effects of stopping. Read the definition before treating a result as the likely experience of everyone who starts.

Safety findings also need their denominators and time period. A headline benefit does not describe the full balance of evidence.

What has changed for UK readers?

A manufacturer’s topline announcement, a conference presentation and a peer-reviewed paper provide different levels of detail. Our news pages identify the material used and show the underlying sources.

Finally, separate research progress from MHRA authorisation, UK launch and NHS funding. A headline can be accurate about one step while telling you little about the others. The useful question is not just “Is this promising?” but “What decision does this evidence actually support?”

Follow the evidence

Sources & further reading

These links support the information above; they do not imply endorsement of this website.

  1. ClinicalTrials.gov: learn about studies
  2. MHRA: medicines regulation
A note on this guide

Written for a UK audience by the Health Comparisons editorial team. This page is an information resource and has not been presented as a clinician’s personal recommendation. Discuss treatment decisions with your prescriber.

Read our editorial standards →